A medicament having inhibitory activity against plasminogen activator inhibitor-1, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof:
wherein R
1
and R
2
represents an aromatic group which may be substituted, W represents a group selected from the following connecting group W-1:
(wherein a bond at the left end binds to the carbon atom and a bond at the right end binds to the nitrogen atom, X represents sulfur atom or NH, Y represents oxygen atom or sulfur atom,
R
3
represents a hydrocarbon group, hydroxy group, or carboxy group),
Z represents a single bond or a connecting group wherein a number of atoms in a main chain is 1 to 3.
Yicathins B and C and Analogues: Total Synthesis, Lipophilicity and Biological Activities
作者:Daniela R. P. Loureiro、Álvaro F. Magalhães、José X. Soares、Joana Pinto、Carlos M. G. Azevedo、Sara Vieira、Ana Henriques、Helena Ferreira、Nuno Neves、Hassan Bousbaa、Salette Reis、Carlos M. M. Afonso、Madalena M. M. Pinto
DOI:10.1002/cmdc.201900735
日期:2020.5.6
and exquisite bioactive compounds. Yicathins B and C are two marine-derived xanthones that have shown antibacterial and antifungal activity. Herein, the totalsynthesis of these yicathins and six novel analogues is reported for the first time. As marine natural products tend to have very lipophilic scaffolds, the lipophilicity of yicathins and their analogues was evaluated in the classical octanol/water